Vinge represents Altor Fund V in connection with its investment in H2 Green Steel. The investment has been carried out in connection with H2 Green Steel's series B round totalling approx. EUR 190 million. Investors participating in the capital raise included, in addition to Altor, inter alia AMF, GIC, Swedbank Robur Alternative Equity, FAM and IMAS Foundation.

H2 Green Steel was founded in 2020 with the ambition to accelerate the decarbonization of the steel industry, using green hydrogen. Steel, which is one of the world’s largest carbon dioxide emitters, is the company’s first business vertical. H2 Green Steel is headquartered in Stockholm, Sweden, with its first green steel plant under development in Boden, northern Sweden.

Vinge's team consisted mainly of Christina Kokko, Johan Larsson, Carl Fredrik Wachtmeister, Linus Adolfsson (M&A), Lisa Hörnqvist, Elis Allmark (Commercial Agreements), Johan Cederblad (Environment), Kristoffer Larsson (Real Estate), Julia Löfqvist (Compliance), Kamyar Najmi (Banking and Finance), Axel Lennartsson (IP), Ebba Svenburg (Employment), Sara Dahlros Sköld and Julia Hagelberg (project assistants).

Related

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025